EBS vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 13, 2026

EBS

58.5
AI Score
VS
EBS Wins

PCRX

50.1
AI Score

Investment Advisor Scores

EBS

59score
Recommendation
HOLD

PCRX

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EBS PCRX Winner
Forward P/E 2.0773 7.8927 EBS
PEG Ratio 0.3835 11.2121 EBS
Revenue Growth -29.7% 5.0% PCRX
Earnings Growth -93.8% -30.0% PCRX
Tradestie Score 58.5/100 50.1/100 EBS
Profit Margin -1.3% 0.7% PCRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, EBS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.